A team of scientists at Sweden’s Linköping University has developed a molecular probe that can detect an array of different amyloid deposits in several human tissues. This new probe is extremely sensitive and was used at very low concentrations to correctly identify every positive amyloidosis sample when compared to the traditional clinical tests. The probe also picked up some amyloidosis signals that the traditional methods were unable to detect. This result means that the new probe could be used to detect amyloidosis before symptoms present, leading to faster and hence more effective treatment.
from Dementia Big http://ift.tt/1VuEpx7
via Stopping Dementia
from WordPress http://ift.tt/1Mxk2In
via alcoholic dementia
http://ift.tt/22z5xwH
No comments:
Post a Comment